期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

WHo2014年版《耐药结核病规划管理指南伙伴手册》解读之六（药物敏感性试验及其方法的合理应用） 被引量：8

下载PDF
导出
摘要 2014年WHO发布的《耐药结核病规划管理指南伙伴手册》（简称“《手册》”）对结核分枝杆菌药物敏感性试验（简称“药敏试验”）做了更新。笔者就《手册》较2008年《耐药结核病规划管理指南》药敏试验更新内容及其合理应用进行解读，以供我国结核病防治工作者借鉴和参考。
作者 段鸿飞
机构地区 首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所结核科
出处 《中国防痨杂志》 CAS 2015年第6期658-659,共2页 Chinese Journal of Antituberculosis
关键词 药物敏感性试验 耐药结核病 管理指南 合理应用 手册 解读 结核分枝杆菌 药敏试验
分类号 R978.1 [医药卫生—药品]
  • 相关文献

参考文献6

  • 1World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-re- sistant tuberculosis. WHO/HTM/TB/2014.11. Geneva: World Health Organization, 2014.
  • 2World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis; emergency update 2008. WHO/HTM/TB/2008. 402. Geneva:World Health Or- ganization, 2008.
  • 3李强,夏辉,欧喜超,赵冰,逄宇,赵雁林.应用线性探针技术与传统药敏试验检测耐药结核病的成本比较[J].中国防痨杂志,2013,35(3):187-190. 被引量：22
  • 4结核病临床诊治进展年度报告（2013年）（第一部分 结核病临床诊断）[J].中国防痨杂志,2014,36(8):714-740. 被引量：13
  • 5Andres S, Hillemann D, Rtisch-Gerdes S, et al. Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany. Antimicrob Agents Chemother, 2014,58(1) ~ 590-592.
  • 6Williamson DA, Roberts SA, Bower JE, et al. Clinical fai- lures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis, 2012,16(2) ..216-220.

二级参考文献69

  • 1王东萍,程红燕,丁运生,林文红,徐东芳,王庆.痰噬菌体生物扩增法检测结核病初治患者中结核分枝杆菌对利福平的耐药性分析[J].中华临床感染病杂志,2013,6(2):114-116. 被引量：1
  • 2Bang DA, Andersen B, Thomsen VO. Rapid genotypic detec- tion of rifampin- and isoniazid-resistant Mycobacterium tubercu- losis directly in clinical specimens. J Clin Microbiol, 2006, 44 (7) :2605-2608.
  • 3Tortoli E, Marcelli F. Use of the INNO LiPA Rif. TB for de- tection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin sus- ceptibility. Eur J Clin Microbiol Infect Dis, 2007, 26 (1): 51-55.
  • 4Lacoma A, Garcia Sierra N, Prat C, et al. GenoType Mtb- DRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical sam- pies. J Clin Microbiol, 2008, 46(11) :3660-3667.
  • 5World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug resistant tuber culosis (MDR-TB). Geneva: WHO, 2008 [2009-11 18]. http://www, who. int/tb/dots/laboratory/lpa_policy, pdf.
  • 6Sohn H, Minion J, Albert H, et al. TB diagnostic tests: how do we figure out their costs? Expert Rev Anti Infect Ther, 2009, 7(6):723-733.
  • 7Kivihya-Ndugga LE, van Cleeff MR, Githui WA, et al. A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. Int J Tuberc Lung Dis, 2003, 7 (12): 1163-1171.
  • 8Sohn H, Sinthuwattanawibool C, Rienthong S, et al. Fluore- scence microscopy is less expensive than Ziehl-Neelsen micro- scopy in Thailand. Int J Tuberc Lung Dis, 2009, 13 (2): 266-268.
  • 9Dowdy DW, Lourenco MC, Cavalcante SC, et al. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults PLoS One, 2008, 3(12): e1057.
  • 10Foundation for Innovative New Diagnostics. FIND prices for GenoType MTBDRplus and Country List. Geneva: Founda- tion for Innovative New Diagnostics, 2009 [2012-12-20]. http://www, finddiagnosties, org/programs/find-negotiated-.

共引文献32

同被引文献77

  • 1陈昶,高文,丁嘉安.纵隔淋巴结结核23例临床分析[J].中国临床医学,2004,11(4):559-560. 被引量：9
  • 2World Health Organization. Global tuberculosis report 2014. WHO/HTM/TB/2014.08. Geneva: World Health Organiza- tion, 2014.
  • 3World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection ot7 tuberculosis and rifampicin resistance: Xpert MTB/RIF as- say for the diagnosis of pulmonary and extrapulmonary TB in adults and children: Policy update. WHO/HTM/TB/ 2013.16. Geneva:World Health Organization, 2013.
  • 4World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug- resistant tuberculosis. WHO/HTM/TB/2014.11. Geneva: Wcrld Health Organization. 2014.
  • 5Brown TJ, Herrera - Leon L, Anthony RM, et al. The use of mac- roarrays for the identification of MDR mycobacterium tuberculosis [J]. J Microbiol Methods, 2006, 65(2) : 294 -300.
  • 6Cavusoglu C, Turhan A, Akinci P, et al. Evaluation of the geno- type MTBDR assay for rapid detection of rifampin and isoniazid re- sistance in mycobacterium tuberculosis isolates[ J]. J Clin Microbi- ol, 2006, 44(7): 2338-2342.
  • 7World Health Organization. Compannion handbook to the WHO guidelines for the programmatic management of drug - resistant tu- bercuosis [ R ]. Geneva : World Health Organization, 2014.
  • 8甄延城,耿红,王银发,徐凌忠,周成超,朱大伟,张小娟.耐药结核病的防治现状及对策研究[J].中国卫生事业管理,2009,26(10):713-714. 被引量：7
  • 9杨刚,李孝鹏.淋巴结病变的影像学进展[J].安徽医学,2010,31(6):694-697. 被引量：3
  • 10菅记涌,王嫩寒,易俊莉,邢青,刘晓雪,王甦民,洪峰.MTBDR plus方法快速检测北京地区临床结核分枝杆菌分离株利福平和异烟肼耐药性效果评价[J].中国防痨杂志,2010,32(10):611-614. 被引量：26

引证文献8

二级引证文献49

中国防痨杂志
2015年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部